Weight Loss Proven Best for Reversing Chronic Obesity Effects, Per NLM Study
As of this week, U.S. Pediatricians report a 40% surge in off-label GLP-1 receptor agonist prescriptions (e.g., semaglutide, liraglutide) for children aged 12–17 with obesity, driven by high-profile trial data ... Read More